Stryker
Trade Stryker 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SYK
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.
SYK Key Statistics
SYK News
Stryker Corp ((SYK)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Pre...
If you have ever wondered whether Stryker is a hidden value play or just priced for perfection, you are not alone. Let's cut through the noise together. While...
Richard Newitter, an analyst from Truist Financial, maintained the Hold rating on Stryker. The associated price target was lowered to $392.00. Elevate Your Inve...
Analyst ratings
73%
of 33 ratingsMore SYK News
Truist analyst Richard Newitter lowered the firm’s price target on Stryker (SYK) to $392 from $407 and keeps a Hold rating on the shares following Q3 results wi...
Stryker, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings from TD Cowen maintained a Buy rating on the stock a...
Evercore ISI lowered the firm’s price target on Stryker (SYK) to $405 from $410 and keeps an Outperform rating on the shares. Stryker’s Q3 performance was solid...
Morgan Stanley analyst Patrick Wood maintained a Buy rating on Stryker today and set a price target of $445.00. Elevate Your Investing Strategy: Take advantage...
Earnings Call Insights Stryker raises 2025 outlook to 9.8%-10.2% organic sales growth as momentum accelerates Oct. 30, 2025 7:17 PM ET Stryker Corporation (SYK)...
Stryker (SYK) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.14 per share. This compares to earnings of $2.87 p...
Reports Q3 revenue $6.1B, consensus $6.04B. “We delivered another quarter of strong sales and double-digit adjusted earnings per share growth,” said Kevin Lobo,...